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Abstract
Background: The efficiency of treating simple bone cyst (SBC) is low. Depending on the choice of treatment, a
positive response occurs in 20 to 80 % of cases. These rates are unacceptable, particularly considering they concern
the treatment of benign lesions affecting children. Although cyst curettage is one of the first known ways of treating
SBC, no precise qualification criteria exists for this procedure. The aim of our study is to identify which type of cyst may
be most effectively treated using curettage with grafting.
Methods: A retrospective analysis was performed on 24 patients referred to our clinic for SBC treatment. To identify
predictive factors, the group of patients who positively responded to treatment (Neer stages I and II, n = 14) were
compared with the group in which recurrences occurred (Neer stages III and IV, n = 10).
Results: Significantly fewer patients with lesions located in the humerus (chi2 = 9.351; p <0.05) and without
pathological facture at the time of diagnosis (p = 0.017) were found in the group with no recurrence. The
following radiological parameters were found to vary significantly between groups: cyst area (z = 3.121; p < 0.01), cyst
index (z = 2.213; p <0.05) and cyst diameter ratio (z = 2.202; p <0.05). In the group with no recurrences, the mean values
of these parameters were found to be lower than in group with poor response to treatment. No statistically significant
differences regarding age, sex or type of bone graft (p > 0.05) were found. Recurrences were experienced by
10 patients (41.7 %) during the 3-year period after surgery
Conclusion: In the group treated with curettage, associations were identified between worse treatment results and
the location in the humerus, pathological fractures at the time of diagnosis, large cyst area, large cyst index and large
cyst diameter.
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Background
Simple bone cysts (SBC) are oval, osteolytic, tumor-like
lesions with a central location. SBCs occur before the
end of bone growth, most commonly in the proximal
humerus and proximal femur. The annual prevalence is
0.3 per 100.000 individuals [1].
Although the etiology of the cysts remains unclear,
there are many possible explanations for their develop-
ment, including inflammation, excessive bone resorption
or incorrect proto-oncogen expression. In addition, dis-
turbed venous blood outflow from fast growing meta-
physis can obstruct intercellular fluid circulation and
leads to cyst formation [2–4]. Inner cyst fluid is known
to have osteoclastic potential as a result of increased con-
centration of prostaglandins, interleukins 1 and 6, tumor
necrosis factor-alpha and lysosomal enzymes [5–7]. Many
authors consider that increased levels of pro-inflammatory
cytokines, osteolytic enzymes, together with a higher
nitric oxide concentration, confirm that inflammation
is a cause of cyst formation [7]. To our knowledge, only
two publications report changes in the genome, these
being a translocation involving chromosomes 16 and 20
[8, 9]. The authors emphasize the need for further re-
search to confirm frequency of these changes and their
etiological relevance.
As etiology is varied, and the choice of treatment strategy
depends on etiology, there are many possible approaches
to treating SBC. The efficiency of steroid treatment con-
firms that the disease has an inflammatory basis [10].
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Proponents of the venous outflow disturbance theory con-
sider the best treatment to be to drain the cyst, either by
drilling, cannulated screw implantation or intramedullary
nailing [11, 12]. However, those who believe excessive
osteoclast activation to be the cause choose bone grafting
procedures using osteoinductive and osteoconductive ma-
terials such as demineralized bone matrix, bone marrow or
cancellous bone graft [13–15].
SBC treatment efficiency is low. Depending on the
choice of treatment, a positive response occurs in 20 to
80 % of cases [16–19]. These rates are unacceptable, par-
ticularly considering they concern the treatment of be-
nign bone lesions affecting children and adolescents.
Treatment failure is established on the basis of lack of
rebuilding progress, recurrences, pathological fractures
or growth disturbances.
In general, treatment strategies of SBCs are technic-
ally simple with relatively low surgical risk. Certain
limits could be the cost of biologically active materials
such as demineralized bone matrix or bone morpho-
genetic protein. When attempting to treat SBC, the sur-
geon should be prepared to perform several surgical
procedures. Accurate treatment selection depends on
patient age, location and disease dynamics. The aim of
our study is to identify which type of cyst may be most
effectively treated using curettage with grafting. The
predictive factors for success of this surgical procedure
will be determined to identify patients who will gain
most benefit from this therapy.
Methods
A retrospective analysis was performed on 24 patients
referred to our clinic for SBC treatment in the period
2005 to 2011. The following study inclusion criteria
applied: participant’s age at the time of surgery <18
years, cyst treated with curettage with bone grafting,
surgical procedure performed at the study site, and
SBC confirmed by pathology (fluid cytology and cyst
wall). Cysts treated with other methods (intramedul-
lary stabilisation, bone marrow injection), or cysts lo-
cated in the spine or the skull were excluded from the
study. The demographic characteristics of the subjects
enrolled for the study together with cyst locations are
presented in Table 1. After identifying the cyst on the
X-ray the following radiological parameters were
determined:
 number of cyst cavities (uni- or multilocular),
 cyst type, according to Enneking’s scale for benign
tumours (latent, active, aggressive) [20],
 cyst area,
 cyst index according to Kaelin and MacEwen [21]
(i.e. the cyst area divided by diaphyseal diameter
squared),
 cyst diameter ratio (i.e. the extent of the lesion on
the longitudinal axis divided by the normal expected
diameter of the long bone) [22],
 minimal cortical thickness,
 ratio of the minimal cortical thickness to the cortical
thickness in the unaffected part of the diaphysis
adjacent to the lesion,
 cyst activity (a cyst located ≤0.5 cm from the growth
plate was considered active, whereas all cysts located
>0.5 cm from the growth plate were considered
latent) [16],
 occurrence of pathological fractures.
Curettage was performed with the use of a bone cur-
ette and a high-speed burr. The adequacy of curettage
was ascertained by direct vision and the procedure was
performed until damage of the fibrous cyst wall occurred
and normal looking bone marrow was seen. A connec-
tion with the medullary canal was created. In cases
where part of the SBC was close to the epiphyseal plate,
only a bone curette was used under direct vision. In ten
cases, resection cavities were filled with tibial autografts
and in fourteen, with deep-frozen allogeneic bone.
The mean follow-up period was 6.2 years (range three
to nine years). The outcomes were evaluated radiologic-
ally: X-rays of the affected limb were taken in standard
positions every three months after surgery and once a
year after cyst resolution. Recurrences were defined ac-
cording to Neer scale as modified by Chang et al. [23].
Stages I and II signified that the therapy was successful,
whereas stages III and IV referred to therapy failure (re-
currence). Limb length was assessed according to the
AO Foundation guidelines, with a 1.5cm difference for
the lower limbs and a 2cm difference for the upper limbs
considered clinically relevant.
To identify predictive factors, the group of patients
who positively responded to treatment (Neer stages I
and II, n = 14, 58.3 %, group 1) were compared with the
Table 1 Demographic data for patients with SBCs
Sample size 24
Age at diagnosis — range (years) 3–17
Mean age (years) 11.58
Females (%) 33.33
Males (%) 66.67
Humerus, n (%) 6 (25)
Femur, n (%) 11 (45.83)
Tibia, n (%) 2 (8.33)
Calcaneus, n (%) 4 (16.67)
Phalanx, n (%) 1 (4.17)
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group in which recurrences occurred (Neer stages III
and IV, n = 10, 41.7 %, group 2).
The χ2 test of independence was used to compare the
number of qualitative parameters in the study groups
and subgroups selected on the basis of different vari-
ables; Yates’ correction was used for small samples. As
most of the parameters analysed in the study were not
normally distributed, the mean values were compared
using non-parametric tests: the Mann–Whitney test for
two groups and the Kruskal-Wallis test for several inde-
pendent groups. The study was approved by the Institu-
tional Review Board.
Results
For further statistical analyze were taken group of patients
with no significant differences regarding age (z = 0.016;
p > 0.05), sex (p = 0.327) or kind of graft (p = 0.257). The
results are presented in Table 2.
Significantly fewer patients with lesions located in the
humerus were found in the group with no recurrence
(chi2 = 9.351; p <0.05, Table 3). Another statistically signifi-
cant difference in both groups is the presence of patho-
logical fractures at the time of diagnosis. The group of
patients with no recurrences included a higher propor-
tion of patients without fractures present before the
beginning of treatment than the group with recurren-
ces.(p = 0.017, Table 3). The following radiological param-
eters were found to vary significantly between groups: cyst
area (z = 3.121; p < 0.01), cyst index (z = 2.213; p <0.05)
and cyst diameter ratio (z = 2.202; p <0.05, Table 3). In the
group with no recurrences, the mean values of these pa-
rameters were found to be lower than in group with poor
response to treatment.
No significant correlations were found regarding loca-
tion (tibia, femur or other), shaft vs metaphysis, active vs
latent lesions, uni- or multilocular lesions, Enneking
classification type or such radiological parameters as
mean cortical thickness or mean ratio of the minimal
cortical thickness to the cortical thickness in the diaph-
ysis (p > 0.05, Table 3).
Recurrences were experienced by 10 patients (41.7 %)
during the 3-year period after surgery. In treating recur-
rences, the following techniques were used: methylpred-
nisolone injection (7 patients, Fig. 1), en bloc excision
followed by transplantation of autogenic fibular grafts
(large cysts, 2 patients) and titanium intramedullary








Sample size, n 14 10
Mean age
(SD), years
11.57 (4.94) 11.6 (2.91) z = 0.016 p > 0.05
Female, n 5 3 p = 0.327
Male, n 9 7
Allogenic bone
graft, n








Recurrence Test value p -value
Sample size 14 10
Cyst location
Humerus, n (%) 1 (7.14) 5 (50.0) χ2 = 9.351 p < 0.05
Femur, n (%) 6 (42.86) 5 (50.0)





Metaphysis, n (%) 7 (50.0) 7 (70.0) p = 0.210
Shaft, n (%) 7 (50.0) 3 (30.0)
Cyst activity
Active cyst, n (%) 4 (28.57) 3 (30.0) p = 0.347
Latent cyst, n (%) 10 (71.43) 7 (70.0)
Number of cavities
Uninocular, n (%) 9 (64.29) 3 (30.0) p = 0.089
Mulitlocular, n (%) 5 (35.71) 7 (70.0)
Pathological fractures at the time of diagnosis
Yes, n (%) 4 (28.57) 8 (80.0) p = 0.017
No, n (%) 10 (71.43) 2 (20.0)
Enneking stage
IA, n (%) 11 (78.57) 5 (50.0) p = 0.089
IB, n (%) 3 (21.43) 4 (40.0)






z = 3.121 p < 0.01





z = 2.213 p < 0.05
Mean cyst diameter
ratio (SD)




0.25 (0.01) 0.19 (0.14) z = 1.202 p > 0.05





0.61 (0.25) 0.41 (0.27) z = 1.784 p > 0.05
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nailing (1 patient, Fig. 2). The follow-up revealed limb
length discrepancy in 4 patients (16.7 %) and patho-
logical fractures were observed in 4 patients (16,7 %): 2
cases of humeral cysts, 1 case of an intertrochanteric
cyst and 1 case of a cyst in the distal tibia.
Discussion
Until the 1980s, the most commonly performed proced-
ure for the treatment of simple bone cysts was curettage
and grafting. This procedure was first reported by Neer
in 1966 [16], who demonstrated that complete healing of
SBC occurred in only about 50 % of a large group of 130
patients. Recurrences occurred in 15 % of patients treated
with this procedure together with additional chemical re-
section of cyst walls (phenol or zinc chloride), and in 39 %
of patients treated with curettage and grafting alone.
Patients with poor response to treatment, 26 % of the
group, had to undergo further surgery.
In 1986, Campanacci et al. gained complete healing
in 46 %, partial healing in 21 % and recurrences in
33 % of patients after curettage with bone grafting.
Most of the recurrences were classified for reopera-
tion. The use of different kinds of grafts (auto or allogenic)
had no effect on the outcome. The author emphasizes that
as free space enables recurrences, the entire lesion lodge
should be filled with grafts. However, the grafts shouldn’t
be packed too tightly, to avoid hindering revascularization
within the cavity [17].
The percentage of failures in the case of curettage is un-
acceptable, especially considering that it is simply treat-
ment of benign tumor-like lesion in adolescents. The way
to lower the recurrence and complication rates is to use an
adjuvant procedure such as chemical or physical resection
(phenol, hydrogen peroxide, liquid nitrogen or argon beam)
[16, 24], which results in a reduced recurrence rate by
broadening the zone of tissue necrosis. In 1997, Schreuder
published a retrospective work evaluating the outcomes of
SBC treatment with curettage, cryosurgery and filling the
cyst cavity with allogenic bone grafts. After mechanical cur-
ettage of the cyst, the author filled the cavity with liquid
nitrogen, which was washed out with warm saline in the
next step. Complete healing was achieved by 50 % of pa-
tients, partial healing in 38 % and recurrences requiring re-
operation in 12 % [24].
A meta-analysis of 12 studies published by Schreuder
was used to compare recurrences after curettage in our
study group to outcomes found in literature [24]. The
mean number of recurrences is 27.4 % of patients, with
the highest percentages of failure being reported by
Bovill et al. (46.6 %) [18] and Mylle et al. (47.6 %) [19],
and the lowest number of recurrences by Peltier et al.
(7.7 %) [25]. The percentage of recurrences in our study
Fig. 1 Example of a patient with SBC with recurrence after curettage and bone grafting treated with steroid injection. a X-ray of the lesion 3 months
postoperatively; (b) recurrence at 9 months postoperatively treated with steroid injection; (c) final result, 3 years postoperatively. The SBC is healed
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is rather high (41.7 %). This may be a result of the fact
that mean follow-up time is quite long (6.2 years), with a
minimal follow-up time of 3 years. Some of the reports
analysed by Schreuder in the meta-analysis note a min-
imal follow-up time 1–2 years, which is a rather short
period of time to observe possible recurrences and re-
building of synthetic osteoconductive materials [17, 26].
Also, the evaluation of cyst rebuilding on the basis of
the Neer scale, the most commonly-used framework, is
not clearly defined. Neer fails to clearly define the mean-
ing of “partial healing” and the correct criteria of recur-
rence and therapy failure. Hence, different values for
cyst area or minimal cortical thickness were chosen to
determine therapy failure. To make the present study
more objective, the Neer scale was used with Chang’s
modification, which defines partial cyst healing as taking
place if the osteolytic lesion takes less than 50 % the
diameter of the bone, with enough cortical thickness to
prevent fracture [23]. Our study assumes the minimal
cortical thickness qualifying to partial healing is 1 mm.
This method of evaluation allows the results qualified in
our work as recurrence to be compared with partial
healing in other works. This study tightens, or rather
systematizes, the criteria for complete healing in re-
sponse to of patient expectations. Nowadays, even chil-
dren regularly take part in sport and are very physically
active. As complete healing means, for both patient and
parents, the ability to return to earlier activity before
diagnosis, the mechanical properties of bone need to be
fully recovered.
Few studies have attempted to evaluate factors predict-
ive of response to different modes of SBC treatment.
After curettage and bone grafting, Neer et al. observed a
higher percentage of recurrences in cysts located in the
proximal parts of the humerus and distal part of the
femur and better results in the tibia and fibula [16].
Campanacci et al. conclude that recurrence rate was higher
in case of active cysts after curettage [17]. Schreuder in his
work evaluating curettage does not report significant
correlations between the risk of recurrence and age,
sex, cyst volume, type of previous treatment procedures
or pathological fractures [24]. Mik does not note any
statistically significant correlation between recurrence
ratio and age (p = 0.055), pathological fracture (p > 0.1)
or cyst activity (p = 0.41). The mean age varies signifi-
cantly between the groups: 8.7 versus 11.3 years. There-
fore, with the probability slightly lower than usual, it
can be assumed that younger children are less likely to
experience satisfactory outcomes [27].
Conclusions
In the group treated with curettage, correlations were
identified between worse treatment results and the loca-
tion in the humerus, pathological fractures at the time of
diagnosis, large cyst area, large cyst index and large cyst
diameter. Such relevance has not been previously re-
ported, because only few authors have analyzed the rea-
sons for recurrence. In the case of previous pathological
fracture, the cavity of the cyst becomes irregular and is
divided by cortical layers, which makes curettage tech-
nically harder to perform and sometimes makes the ex-
cision of complete cyst borders impossible. In the
humerus, the SBC are usually larger with thinner walls
than those in other locations. Due to their asymptomatic
course, they are diagnosed after first fracture. In our
opinion, the higher recurrence rates observed following
this more technically demanding curettage can be attrib-
uted to the large size, thin wall and irregularity of cor-
tical layers after fracture. The presence of statistically
Fig. 2 Example of a patient with SBC with recurrence after curettage
and bone grafting treated with titanium elastic nails. a X-ray of the
lesion at 3 months postoperatively; (b) at 12 months postoperatively;
(c) recurrence with pathological fracture; (d) X-ray follow-up directly
after the titanium elastic nails implantation
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significant predictive factors is due to the high percent-
age of patients with poor outcomes in our study group.
Additionally, as many as 13 factors were compared in
our work; No such detailed comparison has been previ-
ously reported.
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